J0885 – Injection, epoetin alfa, (for non-esrd use), 1000 units
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0885
- Long description
- Injection, epoetin alfa, (for non-esrd use), 1000 units
- Short description
- Epoetin alfa, non-esrd
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2006
- Last change
- January 1, 2006 – No change
Frequently asked questions
What is HCPCS code J0885?
J0885 is a HCPCS Level II code for injection, epoetin alfa, (for non-esrd use), 1000 units.
Does Medicare cover J0885?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0875 – Injection, dalbavancin, 5 mg
- J0877 – Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg
- J0878 – Injection, daptomycin, 1 mg
- J0879 – Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)
- J0881 – Injection, darbepoetin alfa, 1 microgram (non-esrd use)
- J0882 – Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)
- J0883 – Injection, argatroban, 1 mg (for non-esrd use)
- J0884 – Injection, argatroban, 1 mg (for esrd on dialysis)
- J0886 – Injection, epoetin alfa, 1000 units (for esrd on dialysis)
- J0887 – Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- J0888 – Injection, epoetin beta, 1 microgram, (for non esrd use)
- J0889 – Daprodustat, oral, 1 mg, (for esrd on dialysis)
- J0890 – Injection, peginesatide, 0.1 mg (for esrd on dialysis)
- J0891 – Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0892 – Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0893 – Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.